# Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

> **NCT07664397** · PHASE1 · RECRUITING · sponsor: **Robert Flavell, MD, PhD** · enrollment: 40 (estimated)

## Conditions studied

- Bladder Cancer
- Nerve Sheath Tumor
- Nerve Sheath Tumors
- Solid Tumor Malignancies
- Solid Tumor Cancer
- Solid Tumor Neoplasms
- Advanced Solid Tumor
- Bladder Neoplasm
- Nerve Sheath Neoplasms
- Nerve Sheath Tumor, Nos
- Solid Tumor, Adult
- Solid Carcinoma

## Interventions

- **DRUG:** [89Zr]DFO-YS5
- **PROCEDURE:** Positron Emission Tomography (PET)-Computerized tomography (CT)

## Key facts

- **NCT ID:** NCT07664397
- **Lead sponsor:** Robert Flavell, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07664397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07664397, "Imaging Study of [89Zr]DFO-YS5 for Cancer Detection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07664397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*